Biodiversity Literature Repository

Submit to community
Liberated Data
Published November 5, 2019 | Version v1
Journal article Open

Assessment of the insecticidal activity of oral afoxolaner against Phlebotomus perniciosus in dogs

Authors/Creators

  • 1. Boehringer Ingelheim Animal Health, 29 avenue Tony Garnier, 69007 Lyon, France
  • 2. Clinvet, Douar Dbabej Beni Yekhlef, 28815 Mohammedia, Morocco

Description

Perier, Nadège, Lebon, Wilfried, Meyer, Leon, Lekouch, Noua, Aouiche, Nesrine, Beugnet, Frédéric (2019): Assessment of the insecticidal activity of oral afoxolaner against Phlebotomus perniciosus in dogs. Parasite (Paris, France) 26 (63): 1-6, DOI: 10.1051/parasite/2019063, URL: https://doi.org/10.1051/parasite/2019063

Files

source.pdf

Files (237.5 kB)

Name Size
md5:7c4e5d3867403f077efcabee643fb220
237.5 kB Preview Download

Linked records

Additional details

Identifiers

LSID
urn:lsid:plazi.org:pub:7C4E5D3867403F07FFFCFFEE643FB220

References

  • 1. Ballart C, Alcover MM, Picado A, Nieto J, Castillejo S, Portus M, Gallego M. 2013. First survey on canine leishmaniasis in a non classical area of the disease in Spain (Lleida, Catalonia) based on a veterinary questionnaire and a cross-sectional study. Preventive Veterinary Medicine, 109, 116-127.
  • 2. Bergman DK. 1996. Mouthparts and feeding mechanisms of haematophagous arthropods, in The immunology of hostectoparasitic arthropod relationships, Wikel SK, Editor. CAB International: Wallingford, UK. p. 38-45.
  • 3. Beugnet F, Liebenberg J, Halos L. 2015. Comparative efficacy of two oral treatments for dogs containing either afoxolaner or fluralaner against Rhipicephalus sanguineus sensu lato and Dermacentor reticulatus. Veterinary Parasitology, 209, 142-145.
  • 4. Beugnet F, Liebenberg J, Halos L. 2015. Comparative speed of efficacy against Ctenocephalides felis of two oral treatments for dogs containing either afoxolaner or fluralaner. Veterinary Parasitology, 207, 297-301.
  • 5. Beugnet F, de Vos C, Liebenberg J, Halos L, Larsen D, Fourie J. 2016. Efficacy of afoxolaner in a clinical field study in dogs naturally infested with Sarcoptes scabiei. Parasite, 23, 26.
  • 6. Beugnet F, Halos L, Larsen D, de Vos C. 2016. Efficacy of oral afoxolaner for the treatment of canine generalised demodicosis. Parasite, 23, 14.
  • 7. Beugnet F, Halos L, Guillot J. 2018. Textbook of clinical parasitology in dogs and cats. Zaragoza, Spain: Servet Editions. p. 166-174.
  • 8. Carithers D, Crawford J, de Vos C, Lotriet A, Fourie J. 2016. Assessment of afoxolaner efficacy against Otodectes cynotis infestations of dogs. Parasites & Vectors, 9, 635.
  • 9. Colange H. 2011. Contribution a l' etude du repas sanguin de Phlebotomus perniciosus (Diptera : Psychodidae). Toulouse, France: These d' exercice, Medecine veterinaire, Ecole Nationale Veterinaire de Toulouse - ENVT, 78 p.
  • 10. Dereure J, Vanwambeke SO, Male P, Martinez S, Pratlong F, Balard Y, Dedet JP. 2009. The potential effects of global warming on changes in canine leishmaniasis in a focus outside the classical area of the disease in southern France. Vector- Borne Zoonotic Diseases, 9, 687-694.
  • 11. Dolmatova AV, Demina NA. 1971. Les phlebotomes (Phlebotominae) et les maladies qu' ils transmettent. Paris, France: Office de la Recherche Scientifique et Technique d' Outre Mer (ORSTOM), 168 p.
  • 12. European Medicines Agency. 2014. Nexgard® summary of product characteristics. http://www.ema.europa.eu/docs/en_GB/ document_library/EPAR_-_Product_Information/veterinary/ 002729/WC500164067.pdf.
  • 13. Gomez SA, Picado A. 2017. Systemic insecticides used in dogs: potential candidates for phlebotomine vector control? Tropical Medicine & International Health, 22, 755-764.
  • 14. Gomez SA, Lucientes J, Castillo JA, Peris MP, Delacour S, Ortega P, Oropeza RV, Picado A. 2018. A randomized, blinded, controlled trial to assess sand fly mortality of fluralaner administered orally in dogs. Parasites & Vectors, 11, 627.
  • 15. Grammicia M. 2011. Recent advances in leishmaniosis in pet animals: epidemiology, diagnostics and anti-vectorial prophylaxis. Veterinary Parasitology, 8, 23-30.
  • 16. Grammicia M, Gradoni L. 2005. The current status of zoonotic leishmaniases and approaches to disease control. International Journal for Parasitology, 35, 1169-1180.
  • 17. Halos L, Lebon W, Chalvet-Monfray K, Larsen D, Beugnet F. 2014. Immediate efficacy and persistent speed of kill of a novel oral formulation of afoxolaner (NexGard®) against induced infestations with Ixodes ricinus ticks. Parasites & Vectors, 7, 452.
  • 18. Halos L, Carithers DS, Solanki R, Stanford H, Gross SJ. 2015. Preference of dogs between two commercially available oral formulations of ectoparasiticide containing isoxazolines, afoxolaner or fluralaner. Scientific Research Publishing, 5, 25-29.
  • 19. Killick-Kendrick R. 1979. Biology of Leishmania in phlebotomine sandflies, in Biology of the Kinetoplastida, Lumsden WH, Evans DA, Editors. Academic Press: London. p. 395-460.
  • 20. Killick-Kendrick R. 1999. The biology and control of Phlebotomine sand flies. Clinics in Dermatology, 17, 279-289.
  • 21. Letendre L, Huang R, Kvaternick V, Harriman J, Drag M, Soll M. 2014. The intravenous and oral pharmacokinetics of afoxolaner used as a monthly chewable antiparasitic for dogs. Veterinary Parasitology, 201, 190-197.
  • 22. Liebenberg J, Fourie J, Lebon W, Larsen D, Halos L, Beugnet F. 2017. Assessment of the insecticidal activity of afoxolaner against Aedes aegypti in dogs treated with NexGard®. Parasite, 24, 39.
  • 23. Maia C, Cardoso L. 2015. Spread of Leishmania infantum in Europe with dog travelling. Veterinary Parasitology, 30, 2-11.
  • 24. Maroli M, Feliciangeli MD, Bichaud L, Charrel RN, Gradoni L. 2013. Phlebotomine sandflies and the spreading of leishmaniases and other diseases of public health concern. Medical and Veterinary Entomology, 27, 123-147.
  • 25. Miro G, Checa R, Montoya A, Hernandez L, Dado D, Galvez R. 2012. Current situation of Leishmania infantum infection in shelter dogs in northern Spain. Parasites & Vectors, 5, 60.
  • 26. Otranto D, Dantas-Torres F. 2013. The prevention of canine leishmaniasis and its impact on public health. Trends in Parasitology, 29, 339-345.
  • 27. Palatnik-de-Soussa CB, Day MJ. 2011. One health: the global challenge of epidemic and endemic leishmaniasis. Parasite & Vectors, 4, 197.
  • 28. Shoop WL, Hartline EJ, Gould BR, Waddell ME, McDowell RG, Kinney JB, Lahm GP, Long JK, Xu M, Wagerle T, Jones GS, Dietrich RF, Cordova D, Schroeder ME, Rhoades DF, Benner EA, Confalone PN. 2014. Discovery and mode of action of afoxolaner, a new isoxazoline parasiticide for dogs. Veterinary Parasitology, 201, 179-189.
  • 29. Volf P, Volfova V. 2011. Establishment and maintenance of sand fly colonies. Journal of Vector Ecology, 36, S1-S9.
  • 30. World Health Organization. 2010. Control of the leishmaniasis: report of a meeting of the WHO Expert Committee on the Control of Leishmaniases. Geneva. (WHO Technical Report Series, 949).